期刊文献+

大黄素甲醚对胰腺癌SW1990细胞的杀伤作用及其机制 被引量:5

Mechanism and inhibitory effect of physcion on pancreatic cancer cell SW1990
下载PDF
导出
摘要 目的观察大黄素甲醚对胰腺癌SW1990细胞增殖、细胞周期及凋亡的影响,并探讨其作用机制。方法 Western印迹检测不同浓度大黄素甲醚干预后PI3K/Akt信号通路蛋白水平,MTT检测不同浓度、时间下,大黄素甲醚对SW1990细胞增殖的影响。流式细胞术检测大黄素甲醚对SW1990周期及凋亡的影响。结果与NC组比较,Physcion组m TOR及p-Akt表达水平呈剂量依赖性下降,Akt表达呈剂量依赖性上升,其中5、50μmol/L组与NC组比较差异有统计学意义(P<0.05);Physcion组细胞存活率呈时间依赖性下降,在48、72、96h时,与NC组比较差异有统计学意义(P<0.05)。Physcion组SW1990存活率呈剂量依赖性下降,其中0.5、5、50μmol/L组与NC组比较差异有统计学意义(P<0.05);与NC组比较,Physcion组停留在G1、G2期细胞比例减少,S期细胞比例升高(P<0.05);Physcion组凋亡率高于NC组(P<0.01)。结论大黄素甲醚通过抑制Akt磷酸化,调控PI3K/Akt通路,降低胰腺癌细胞存活率,促进其凋亡。 Objective To observe the effect of physcion on proliferation and apoptosis of pancreatic cancer cell SW1990 and discuss the mechanism.Methods The PI3K-Akt-mTOR signaling pathway was detected by western blot;the proliferation of SW1990 interfered with different concentration of physcion at different time points was observed by MTT assay;the cell cycle and apoptosis affected by physcion was detected by flow cytometry.Results Compared with NC group,the expression of mTOR and p-Akt in physcion groups was dose-dependently decreased,while the expression of Akt was dose-dependently increased;there were significant differences at 5 μmol/L and 50μmol/L(P〈0.05).The cell viability in physcion groups was decreased in a time-dependent or dose-dependent manner,the differences being significant at 48,72 and 96 h(P〈0.05) or 0.5,5 and 50 μmol/L(P〈0.05).Physcion group has fewer cells staying in phase G1 and G2 and more cells staying in phase S than NC group(P〈0.05) with higher apoptosis rate(P〈0.01).Conclusion Physcion decreases the cell viability of pancreatic cancer and promotes the apoptosis by inhibiting the phosphorylation of Akt and controlling the PI3K/Akt pathway.
作者 杨勇
出处 《实用药物与临床》 CAS 2016年第12期1482-1485,共4页 Practical Pharmacy and Clinical Remedies
关键词 胰腺癌 大黄素甲醚 凋亡 Pancreatic cancer Physcion Apoptosis
  • 相关文献

参考文献7

二级参考文献128

  • 1杨炳奎,霍介格,曹振健.中医药治疗中晚期胰腺癌68例临床观察[J].中国中医基础医学杂志,2002,8(4):56-58. 被引量:30
  • 2陈小东,梁启廉,李小英,张英,李建文,梁柱,张远起.复方丹参滴丸在41例中晚期胰腺癌化疗中的应用[J].肿瘤学杂志,2005,11(1):46-48. 被引量:6
  • 3李慧,杨洁,康迅雷,李玲娜,易静.大黄素提高砷剂抑瘤效果的体内研究[J].上海第二医科大学学报,2005,25(7):666-670. 被引量:3
  • 4Lee K S, Lee H J, Ahn K S, et al. Cyclooxygenase-2/prostaglan- din E2 pathway mediates icariside II induced apoptosis in human PC-3 prostate cancer cells [ J ]. Cancer Lett, 2009, 280 ( 1 ) : 93.
  • 5Kang Y j, Chung H J, Nam J W, et al. Cytotoxic and antineo- plastic activity of timosaponin A-Ill for human colon cancer cells [J]. JNat Prod, 2011, 74(4):701.
  • 6King F W, Fong S, Griffin C, et al. Timosaponin AIll is preferen- tially cytotoxic to tumor cells through inhibition of mTOR and in- duction of ER stress [ J]. PLoS One, 2009, 4(9) : e7283.
  • 7Sy L K, Yah S C, Lok C N, et aL Timosaponin A-Ill induees au- tophagy preceding mitochondria-mediated apoptosis in Hel,a cancer cells [J]. Cancer Res, 2008, 68(24) : 10229.
  • 8Fujioka S, Yoshida K, Yanagisawa S, et al. Angiogenesis in pan- creatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predic- tors of overall and relapse-free survival [ J] Cancer, 2001, 92 (7) : 1788.
  • 9Wey J S, Fan F, Gray M J. Vascular endothelial growth factor re- ceptor-1 promotes migration and invasion in pancreatic carcinoma cell lines [J]. Cancer, 2005, 104(2): 427.
  • 10Japan pancreas Society.Classification of pancreatic carcinoma, 1st ed[M].Tokyo: Kanehara Shuppan Company Press, 1996 : 2-8.

共引文献80

同被引文献79

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部